Voloridge Investment Management
ANIP icon

Voloridge Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Voloridge Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,027
Closed -$277K – 1133
2025
Q3 		$277K Buy
+3,027
New +$247K ﹤0.01% 1130
2024
Q2 		– Sell
-13,346
Closed -$923K – 1190
2024
Q1 		$923K Buy
+13,346
New +$806K ﹤0.01% 977
2023
Q4 		– Sell
-29,706
Closed -$1.72M – 1147
2023
Q3 		$1.72M Buy
+29,706
New +$1.71M 0.01% 962

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management's ANIP Position: Q4 2025 in Review

Voloridge Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2025, closing a stake of 3,027 shares — an estimated $277K sold.

Voloridge Investment Management first reported a position in ANIP in Q3 2023 and held it in 3 quarters. The position peaked at $1.72M in Q3 2023. 284 funds tracked by Wall St. Rank hold ANIP as of Q4 2025.

  • Voloridge Investment Management reported no remaining ANI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 3,027 ANI Pharmaceuticals shares in Q4 2025, an estimated $277K.
  • Voloridge Investment Management first reported a position in ANI Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Voloridge Investment Management's ANI Pharmaceuticals position peaked at $1.72M in Q3 2023.
  • 284 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.